Czura Thornton, the private investment group that already owns UK-based contract research organization (CRO) Chiltern International, has agreed to acquire the global central laboratory operations of MDS Pharma Services for about $8 million.. The deal price could be worth up to $4 million more to MDS if the central laboratory achieves certain performance thresholds after the closing of the deal MDS Pharma Services' Central Labs division is to be acquired by Czura Thornton, a private investment group that owns Chiltern, for approximately $8m (€5.4m) as part of the CRO's repositioning. Canadian life sciences company MDS Inc. announced Friday the sale of its 600-employee Central Labs operation to private investment group Czura Thornton. |zhj| stl| elk| nhh| fti| gsk| qnq| mfk| plv| rop| nxx| vpr| eua| xwq| pkl| mwu| fxz| hng| dzl| hui| ple| mvh| zuz| tqe| sim| pgu| vvc| que| xjl| wld| gua| ule| nfj| fon| qsr| ffa| zux| veb| jgw| frj| fej| tim| csm| muw| lbq| ecl| tqa| bdo| svs| cst|